Furthermore, in both low-density lipoprotein receptor null (LDLR−/−) and apolipoprotein E deficient (ApoE−/−) mice, genetic disruption of FPR2 results in reduced atherosclerosis development [101,102]. The gene discussed is APOE; the disease is atherosclerosis.